IP Library › Granted Patent US 12,551,580
Granted Patent B2
US 12,551,580 · App. 18/402,399 · Granted Feb 17, 2026

Heterocyclic compounds and imaging agents for imaging Huntington protein

Inventors: Longbin Liu (Thousand Oaks, CA); Matthew Lee (San Diego, CA); Celia Dominguez (Los Angeles, CA); Peter David Johnson (Wantage, GB); Catherine Jane Greenaway (Banbury, GB); Kanika Khurana (London, GB); Matthew Robert Mills (Wantage, GB); Filippo Rota (Bristol, GB)
Assignee: CHDI Foundation, Inc.
A61K51/0459A61K51/0455A61K51/0463C07B59/002C07D231/12C07D471/04C07D487/04C07D487/14C07D519/00C07B2200/05
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,551,580
App. No.
18/402,399
Granted
Feb 17, 2026
Kind
B2
Abstract

Provided herein are certain compounds and imaging agents useful for detecting a disease or condition associated with protein aggregation, compositions thereof, and methods of their use.

Claims (20)

1 . A compound of Formula Ila:

or an isotopically enriched analog, pharmaceutically acceptable salt, tautomer, stereoisomer, or a mixture of stereoisomers thereof,

wherein the compound is labeled with one or more positron-emitting radioactive isotopes selected from 11 C, 13 N, 15 O, and 18 F;

R 23 is hydrogen, halo, cyano, hydroxy, amino, alkylamino, dialkylamino, C 1-4 alkyl, C 1 -4haloalkyl, C 1-4 alkoxy, C 1-4 haloalkoxy, or C 3-6 cycloalkyl;

R 3 is methyl;

each of R 11 , R 12 , R 13 , and R 14 is independently hydrogen, halo, cyano, hydroxy, amino, alkylamino, dialkylamino, C 1-4 alkyl, C 1-4 haloalkyl, C 1-4 alkoxy, or C 1-4 haloalkoxy;

L is —(C(R 6 ) 2 ) m —, wherein m is 1, 2, 3, or 4;

each R 6 is independently hydrogen, halo, cyano, hydroxy, amino, alkylamino, dialkylamino, C 1-4 alkyl, C 1-4 haloalkyl, C 1-4 alkoxy, or C 1-4 haloalkoxy; or

two R 6 , together with any intervening atoms, join to form a 3- to 6-membered ring;

R a is hydrogen, C 1-6 alkyl, or C 1-6 haloalkyl;

R b is -L 2 -X 1 ;

L 2 is absent;

X 1 is C 3-10 cycloalkyl, C 6-10 aryl, heteroaryl, or heterocyclyl, wherein X 1 is optionally substituted with 1 to 4 R 4 ; and

each R 4 is independently halo, cyano, hydroxy, amino, alkylamino, dialkylamino, C 1-4 alkyl, C 1-4 haloalkyl, C 1-4 alkoxy, or C 1-4 haloalkoxy;

or R a and R b , along with any intervening atoms, form a 3- to 10-membered heterocyclyl ring optionally substituted by 1 to 4 R 4 .

2 . The compound of claim 1 , wherein X 1 is C 6-10 aryl.

3 . The compound of claim 1 , wherein X 1 is heteroaryl or heterocyclyl.

4 . The compound of claim 1 , wherein each R 4 is independently halo, hydroxy, C 1-4 alkyl, C 1-4 haloalkyl, or C 1-4 alkoxy.

5 . The compound of claim 1 , wherein m is 2.

6 . The compound of claim 1 , wherein one of R 11 , R 12 , R 13 , or R 14 is halo.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2025
From: EVOTEC (UK) LTD.
To: CHDI FOUNDATION, INC.
Reel/Frame 071594/0580 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2025
From: JOHNSON, PETER DAVID; GREENAWAY, CATHERINE JANE; KHURANA, KANIKA; MILLS, MATTHEW ROBERT; ROTA, FILIPPO
To: EVOTEC (UK) LTD.
Reel/Frame 071591/0562 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2025
From: LIU, LONGBIN; LEE, MATTHEW; DOMINGUEZ, CELIA
To: CHDI FOUNDATION, INC.
Reel/Frame 071594/0574 →
Continuity (3)
Continuation 17344582 · Jun 10, 2021
Provisional Application 63037751 · Jun 11, 2020
Related Publication 20240342317A1 · Oct 17, 2024
References Cited (38)
US 5405847A · Dieter et al. · 1995 [cited by applicant]
US 11071793B2 · Dominguez et al. · 2021 [cited by applicant]
US 11918662B2 · Liu et al. · 2024 [cited by applicant]
US 12036291B2 · Dominguez et al. · 2024 [cited by applicant]
US 20100168084A1 · Huber et al. · 2010 [cited by applicant]
US 20110257184A1 · Qu et al. · 2011 [cited by applicant]
US 20230159531A1 · Liu et al. · 2023 [cited by applicant]
EP 1798233A1 · 2007 [cited by applicant]
WO WO9616644A1 · 1996 [cited by applicant]
WO WO2005028474A2 · 2005 [cited by applicant]
WO WO2005041664A1 · 2005 [cited by applicant]
WO WO2006072608A2 · 2006 [cited by applicant]
WO WO2006094210A2 · 2006 [cited by applicant]
WO WO2008017883A2 · 2008 [cited by applicant]
WO WO2008041264A1 · 2008 [cited by applicant]
WO WO2009073620A2 · 2009 [cited by applicant]
WO WO2010016005A1 · 2010 [cited by applicant]
WO WO2010135571A1 · 2010 [cited by applicant]
WO 2011110546A2 · 2011 [cited by applicant]
WO WO2012078633A2 · 2012 [cited by applicant]
WO WO2013003383A2 · 2013 [cited by applicant]
WO WO2013019469A1 · 2013 [cited by applicant]
WO WO2013040321A1 · 2013 [cited by applicant]
WO WO2016033436A1 · 2016 [cited by applicant]
WO WO2017040336A1 · 2017 [cited by applicant]
WO WO2017062751A1 · 2017 [cited by applicant]
WO WO2017153601A1 · 2017 [cited by applicant]
WO WO2018204370A1 · 2018 [cited by applicant]
WO WO2019084271A1 · 2019 [cited by applicant]
International Search Report and Written Opinion for PCT/US2021/036830, Oct. 22, 2021, 14 pages. [cited by applicant]
Gennaro Pagano et al, “Current status of PET imaging in Huntington's disease”, 2016, vol. 43, No. 6, p. 1171-1182. [cited by applicant]
Kevin J. Frankowski et al., “Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy”, ACS Chemical Neuroscience, vol. 3, No. 3, pp. 221-236 (2012). [cited by applicant]
Giuseppe Campiani et al., “Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-… [cited by applicant]
CAS Registry Nos. Beginning with RN 1112363-69-5, which entered STN on Feb. 26, 2009. 466 pages. [cited by applicant]
Pubchem, Database accession No. 2740936, Entered Pubchem 2005, downloaded from https://pubchem.ncbi.nlm.nih.gov/ on May 28, 2025. [cited by applicant]
Pubchem, Database accession No. 44121667, Entered Pubchem 2009, downloaded from https://pubchem.ncbi.nlm.nih.gov/ on May 28, 2025. [cited by applicant]
Registry of STN.CAS. Entered STN:2006, 2009, 892371-94-7/RN etc. for 16 compounds, Entered STN:Jul. 12, 2006; 1110972-08-1/RN etc. for 13 compounds, Entered STN:Feb. 24, 2009. 29 pages. [cited by applicant]
CAS Registry Nos. beginning with 1171769-52-0, which entered STN on Aug. 2, 2009, 24 pages. [cited by applicant]
Cited By (1)
US 12,705,744